Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.45p
   
  • Change Today:
    -0.050p
  • 52 Week High: 3.15
  • 52 Week Low: 0.41
  • Currency: UK Pounds
  • Shares Issued: 374.35m
  • Volume: 7,364,594
  • Market Cap: £1.68m
  • RiskGrade: 435

Latest ShareCast News

ValiRx terminates exclusive negotiations with TheoremRx

By Josh White

Date: Thursday 03 Apr 2025

(Sharecast News) - ValiRx announced the immediate termination of its letter of intent with TheoremRx on Thursday, ending exclusive negotiations originally set to run until 31 May.

Valirx ShareCast News

ValiRx's Inaphaea inks deal with UK-based Screen... 03-Feb-2025 ShareCast
ValiRx enters evaluation and option deal with Ca... 29-Jan-2025 ShareCast
ValiRx further extends letter of intent with The... 31-Dec-2024 ShareCast
ValiRx shares tank on £1.6m fundraising plan to ... 09-Dec-2024 ShareCast
ValiRx subsidiary makes first sale 18-Nov-2024 ShareCast

Valirx Regulatory News

Holding(s) in Company 06-Jun-2025 10:54 RNS
Final Results & Notice of AGM 06-Jun-2025 07:00 RNS
New Evaluation and Material Transfer Agreement 03-Jun-2025 07:00 RNS
Holding(s) in Company 20-May-2025 13:25 RNS
Inaphaea Deal Extension With Dominion 12-May-2025 07:00 RNS

Valirx Newspaper Links

Business Digest 24-Sep-2006 Sunday Times

Valirx Tips & Analysis

IOS acquires Indian restaurants owner 30-Jan-2008 Times
Small caps 13-Nov-2007 Times
Kelda springs to life as takeover talk bubbles up 11-Sep-2007 Telegraph
Kelda climbs on revived takeover speculation 11-Sep-2007 The Independent
Alliance & Leicester buoyed by talk of NAB bid 09-Aug-2007 The Independent

Valirx News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.45p
Change Today -0.050p
% Change -10.00 %
52 Week High 3.15
52 Week Low 0.41
Volume 7,364,594
Shares Issued 374.35m
Market Cap £1.68m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.22% above the market average41.22% above the market average41.22% above the market average41.22% above the market average41.22% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Price Trend
97.99% below the market average97.99% below the market average97.99% below the market average97.99% below the market average97.99% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
23.61% above the market average23.61% above the market average23.61% above the market average23.61% above the market average23.61% above the market average
26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average

Valirx Dividends

No dividends found

Trades for 06-Jun-2025

Time Volume / Share Price
13:22 100,000 @ 0.49p
13:18 50 @ 0.49p
12:53 1,274,256 @ 0.47p
12:50 150,000 @ 0.45p
12:49 11,664 @ 0.45p

Valirx Key Personnel

CFO Gerald Desler

Top of Page